Ruti Aga Banned for Six Years: Two for the Drug, Four for a Prescription That Never Existed

There was a half marathon in China in March. Ruti Aga won it. The Athletics Integrity Unit (AIU) statement does not record a single time from that race — not the winning mark, not a split, not the strength of the field. What it records is a piece of paper: a prescription pad belonging to a clinic that did not exist, signed by a man who is not a registered doctor, about which the clinic in question issued a flat denial when he claimed the pad came from "a former workplace."

I know I should have started with the time. Seventeen years ago I walked off a legacy desk to follow a track that had no guarantee, and the habit since then is to find the number first, because the number is what makes a story survive contact with the scene. This story has no number. That absence is the information: a six-year ban has been built on a race whose performance record the public never received.

Aga is an Ethiopian marathoner, 32. The AIU said on Thursday that her sample after the March race contained methylprednisolone — two years for that. The tampering charge was proven — four more. Six years in total, dated from 10 September, which is also when her provisional suspension began.

She is the athlete who won the 2026 Tokyo Marathon and finished second at three World Marathon Majors. Berlin 2026's 2:18:34 sits in her record — though that figure is not in the AIU statement, it is in my own sheet, so read it as a claim and not as evidence. What the statement does say is that the violation is anchored to the March race, with no announced reach backwards. The 2026 major title does not erase itself — not unless an earlier-use finding arrives.

Now the error that has been repeated most widely. Methylprednisolone is not an anabolic steroid. It is a glucocorticoid, class S9 on the WADA Prohibited List, and it is prohibited in-competition only — by injection, oral or rectal route. What was printed as a "prohibited steroid" is an anti-inflammatory, and that distinction rewrites the entire legal basis of the case.

On the roads, the testing window opens at 23:59 the night before the race. A therapeutic knee injection given out of competition is entirely lawful; it becomes a violation only if residues are present in-competition. Aga therefore had a defence that could actually have worked: medical records, disclosure of route, an account of timing.

She destroyed it herself. A knee injury was cited, the prescription was written by a family member, and three separate verifications failed at once: the clinic did not exist, the author was not on any medical register, and the clinic disowned the pad. Genuine treatment gets defended with genuine paperwork. Paperwork gets forged when there is none.

Read the arithmetic plainly: two years for presence, four for tampering. The sum does not demonstrate AIU severity; it demonstrates that the panel rejected the no-significant-fault discount. Two years is the standard outcome for a Specified Substance where intent is not proven; four is the Code's ordinary tampering sanction. Backdating to 10 September is procedure, not relief — provisional suspension time simply counts.

The career math is harsher. Thirty-two plus six means a return at 38. Ethiopian women's marathon depth does not hand a national-team slot to a 2:18 athlete automatically; a 38-year-old returning with a doping record is close to unselectable. Six years for a glucocorticoid with no proven endurance benefit is the real sentence in this file.

Here I have to borrow the language of another sport and then name where it breaks. Every transfer window is a tactics room with louder agents and worse lighting. China's label-race circuit is the between-majors income tier for East African marathoners — appearance fee, low race count, manageable risk. The analogy fails immediately: athletics has no league, no franchise, no transfer fee. An athlete's real contract is an appearance fee plus an agent, and the federation pays no salary. In India the picture inverts — the actual payroll is a Railways, Services, police or PSU job, which is exactly why an Indian runner rarely has the structure to fund a lawyer and a team physician. I have learned to read the scoreboard and the balance sheet as one text, and here the biggest line-item loss on the balance sheet is medical support.

This is where I dissent. The six years will be sold as rigour, and simultaneously as disproportionate enforcement against African road runners. Both readings are easy, which makes both suspect. My reading is that the drug was never the subject — the document was. The knee injury was real, the treatment probably real, and the only counterfeit item a single prescription. So let me state the falsifier inside the piece: if the reasoned decision shows the panel escalated the two-year presence sanction on intent, my reading is wrong. And if a CAS appeal turns on interview language and translation, the four-year tampering limb looks brittle.

Go back to the root. Marathoners race on chronic knee pathology because appearance fees are paid for starting, not for healing. The cheapest tool is a glucocorticoid injection, and the network around it is informal. An athlete without a credentialed team physician does not apply for a TUE — she improvises. The forged pad is what improvisation looks like on paper.

Three things to watch. One, the CAS window, typically about 21 days from the reasoned decision. Two, how many similarly profiled cases emerge from the same Chinese circuit and the same training clusters in the next few months — that count matters more than six years. Three, that the AIU's next frontier is document verification rather than sample analysis, and in that fight the athlete without a lawyer loses first.

One question stays pinned to my desk: if the time from that March race was never published, what exactly was the six-year sentence for — the speed, or the paper built to hide it?